| Name | BMS-986299 |
|---|---|
| Synonyms |
N-((4-Amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl)methyl)-N-ethylacetamide
BMS986299, 10 mM in DMSO Acetamide, N-[[4-amino-7-(1H-pyrazol-3-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl |
| Description | BMS-986299 (compound 112) is a first-in-class NLRP3 inflammasome agonist with an EC50 of 1.28 μM. (patent WO2018152396A1). |
|---|---|
| Related Catalog | |
| Target |
NLRP3:1.28 μM (EC50) |
| References |
[1]. Gary Glick, et al. Substituted imidazo-quinolines as nlrp3 modulators. WO2018152396A1. |
| Molecular Formula | C18H19N7O |
|---|---|
| Molecular Weight | 349.39 |